首页
(current)
大学
论文
新闻
招聘
FAQ
简体中文
中
En
登录
注册
#Sukesh Voruganti
Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA
胃癌基础与临床转化研究实验室 , 中国科学院
Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation
胃癌基础与临床转化研究实验室 , 中国科学院
Abstract 2433: A novel MDM2 inhibitor suppresses breast cancer growth and metastasis
胃癌基础与临床转化研究实验室 , 中国科学院
Abstract 2434: The anticancer activity of Japonicone A is mediated by inhibiting NFAT1-MDM2 pathway
胃癌基础与临床转化研究实验室 , 中国科学院
Abstract C93: RYBP predicts survival of patients with non-small cell lung cancer and sensitizes chemotherapy
胃癌基础与临床转化研究实验室 , 中国科学院
Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy
胃癌基础与临床转化研究实验室 , 中国科学院
Natural Product Ginsenoside 25-OCH3-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2
胃癌基础与临床转化研究实验室 , 中国科学院
Abstract 5266: RYBP expression predicts survival of patients with hepatocellular carcinoma, and regulates response to chemotherapy
胃癌基础与临床转化研究实验室 , 中国科学院
miRNAs in Cancer Prevention and Treatment and as Molecular Targets for Natural Product Anticancer Agents
胃癌基础与临床转化研究实验室 , 中国科学院
The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models
胃癌基础与临床转化研究实验室 , 中国科学院
Identification of a New Class of MDM2 Inhibitor That Inhibits Growth of Orthotopic Pancreatic Tumors in Mice
胃癌基础与临床转化研究实验室 , 中国科学院
Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action
胃癌基础与临床转化研究实验室 , 中国科学院
Discovery and Characterization of Dual Inhibitors of MDM2 and NFAT1 for Pancreatic Cancer Therapy
胃癌基础与临床转化研究实验室 , 中国科学院
Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications
胃癌基础与临床转化研究实验室 , 中国科学院
RYBP predicts survival of patients with non-small cell lung cancer and regulates tumor cell growth and the response to chemotherapy
胃癌基础与临床转化研究实验室 , 中国科学院
Development and validation of an HPLC-MS/MS analytical method for quantitative analysis of TCBA-TPQ, a novel anticancer makaluvamine analog, and application in a pharmacokinetic study in rats
胃癌基础与临床转化研究实验室 , 中国科学院
Development and validation of a rapid HPLC method for quantitation of SP-141, a novel pyrido[b]indole anticancer agent, and an initial pharmacokinetic study in mice
胃癌基础与临床转化研究实验室 , 中国科学院
RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo
胃癌基础与临床转化研究实验室 , 中国科学院
Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula lineariifolia Turcz.
胃癌基础与临床转化研究实验室 , 中国科学院